These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 39256877)

  • 21. Contribution of alpha-synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI.
    Abu-Rumeileh S; Arajyan G; Reiman EM; Otto M; Weise CM;
    Alzheimers Dement; 2024 Oct; 20(10):7411-7419. PubMed ID: 39177111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
    Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-Synuclein Seed Amplification in CSF and Brain from Patients with Different Brain Distributions of Pathological α-Synuclein in the Context of Co-Pathology and Non-LBD Diagnoses.
    Arnold MR; Coughlin DG; Brumbach BH; Smirnov DS; Concha-Marambio L; Farris CM; Ma Y; Kim Y; Wilson EN; Kaye JA; Hiniker A; Woltjer RL; Galasko DR; Quinn JF
    Ann Neurol; 2022 Oct; 92(4):650-662. PubMed ID: 35808984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient with rapidly evolving neurological disease with neuropathological lesions of Creutzfeldt-Jakob disease, Lewy body dementia, chronic subcortical vascular encephalopathy and meningothelial meningioma.
    Vita MG; Tiple D; Bizzarro A; Ladogana A; Colaizzo E; Capellari S; Rossi M; Parchi P; Masullo C; Pocchiari M
    Neuropathology; 2017 Apr; 37(2):110-115. PubMed ID: 27634418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
    Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
    J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases.
    Kon T; Tomiyama M; Wakabayashi K
    Neuropathology; 2020 Feb; 40(1):30-39. PubMed ID: 31498507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The promise of amplification assays for accurate early detection of α-synucleinopathies: A review.
    Kurapova R; Chouliaras L; O'Brien JT
    Exp Gerontol; 2022 Aug; 165():111842. PubMed ID: 35623540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
    Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological Correlations and Concomitant Pathologies in Rapidly Progressive Dementia: A Brain Bank Series.
    Grau-Rivera O; Gelpi E; Nos C; Gaig C; Ferrer I; Saiz A; Lladó A; Molinuevo JL; Graus F; Sánchez-Valle R;
    Neurodegener Dis; 2015; 15(6):350-60. PubMed ID: 26523804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases.
    Ruffmann C; Calboli FC; Bravi I; Gveric D; Curry LK; de Smith A; Pavlou S; Buxton JL; Blakemore AI; Takousis P; Molloy S; Piccini P; Dexter DT; Roncaroli F; Gentleman SM; Middleton LT
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):436-50. PubMed ID: 26527105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease.
    Chitravas N; Jung RS; Kofskey DM; Blevins JE; Gambetti P; Leigh RJ; Cohen ML
    Ann Neurol; 2011 Sep; 70(3):437-44. PubMed ID: 21674591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families.
    Tsuang DW; Dalan AM; Eugenio CJ; Poorkaj P; Limprasert P; La Spada AR; Steinbart EJ; Bird TD; Leverenz JB
    Arch Neurol; 2002 Oct; 59(10):1622-30. PubMed ID: 12374501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional Overlap of Pathologies in Lewy Body Disorders.
    Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
    J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology.
    Bayram E; Coughlin DG; Rajmohan R; Litvan I
    Biol Sex Differ; 2024 Jan; 15(1):8. PubMed ID: 38243325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
    Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seeding Propensity and Characteristics of Pathogenic αSyn Assemblies in Formalin-Fixed Human Tissue from the Enteric Nervous System, Olfactory Bulb, and Brainstem in Cases Staged for Parkinson's Disease.
    Fenyi A; Duyckaerts C; Bousset L; Braak H; Del Tredici K; Melki R; On Behalf Of The Brainbank Neuro-Ceb Neuropathology Network
    Cells; 2021 Jan; 10(1):. PubMed ID: 33445653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.